What is the generic name of the medication marketed as Viibryd?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Generic Name for Vilazodone

The generic name for the medication marketed as Viibryd is vilazodone hydrochloride (HCl). 1

Medication Details

Vilazodone hydrochloride is the active pharmaceutical ingredient in Viibryd tablets. The drug is formulated as polymorph Form IV vilazodone hydrochloride and is available in three tablet strengths: 10 mg, 20 mg, and 40 mg 1.

Chemical Structure

The complete chemical name is: 2-benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piprazinyl]-, hydrochloride (1:1), with a molecular weight of 477.99 1.

Pharmacological Classification

Vilazodone is classified as a dual-acting antidepressant that combines:

  • Selective serotonin reuptake inhibitor (SSRI) properties
  • 5-HT1A receptor partial agonist activity

This multimodal mechanism distinguishes it from traditional SSRIs 2, 3, 4.

FDA Approval Status

Vilazodone was approved by the U.S. Food and Drug Administration in January 2011 for the treatment of major depressive disorder (MDD) in adults 5, 6. It is not approved for use in children 1.

The brand name Viibryd and generic name vilazodone refer to the same medication, with vilazodone hydrochloride being the precise chemical form used in the formulation 1.

References

Research

Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2012

Research

Vilazodone: a novel antidepressant.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012

Research

Vilazodone (Viibryd)--a new antidepressant.

The Medical letter on drugs and therapeutics, 2011

Research

Vilazodone: another novel atypical antidepressant drug.

Journal of psychosocial nursing and mental health services, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.